Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
about
Clinical validity and utility of genetic risk scores in prostate cancerNew developments in the medical management of prostate cancer.Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA compendium of genome-wide associations for cancer: critical synopsis and reappraisal.Prostate cancer risk alleles are associated with prostate cancer volume and prostate size.An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysisGenome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity.Prostate cancer in young men: an important clinical entity.Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer.Prostate cancer as a model for tumour immunotherapy.Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examinationAssessing interactions of two loci (rs4242382 and rs10486567) in familial prostate cancer: statistical evaluation of epistasis.Screening for familial and hereditary prostate cancer.Associations of ChREBP and Global DNA Methylation with Genetic and Environmental Factors in Chinese Healthy AdultsThe role of the BRCA2 gene in susceptibility to prostate cancer revisitedAssociations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer.The burden of prostate cancer in Canada.Sequence variants at 22q13 are associated with prostate cancer risk.Estimation of absolute risk for prostate cancer using genetic markers and family history.Identifying association model for single-nucleotide polymorphisms of ORAI1 gene for breast cancerEarly detection of prostate cancer with emphasis on genetic markers.Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.Multigene panels in prostate cancer risk assessment: a systematic review.Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies.Number of prostate cancer risk alleles may identify possibly 'insignificant' disease.Pathological outcomes associated with the 17q prostate cancer risk variants.Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study.
P2860
Q26746219-D03215DA-604F-4B71-9F51-4B22D782FD07Q33566738-09330CEC-00B9-4407-8DB8-C56BD0EFC513Q33782243-4C772777-2536-4F0E-9CB0-59F915790B9BQ33915049-184E24CC-EFAB-431D-AE42-503160C05269Q33935064-4E06359F-F94C-42D2-B7C1-92872B5430F2Q34071472-551859B6-E988-46C9-BC25-492AC9082846Q34241300-7ADFAF6A-D477-4058-BE9D-33A3DAAD8B63Q34314644-FD0BCE95-AA39-4035-9CE8-ACEC8DC3F1ADQ34689090-70312D70-E9D7-4D90-995B-56F6A2461D4EQ34856875-02BEC075-9FCD-47D5-917C-EC3D6D545529Q34946649-9B9B1CC5-031D-4EE4-A852-0C12BFF63827Q35107494-D9C7789E-C5F4-4CBB-9F05-DBBAA5DFBA80Q35861576-14022B1C-53BE-4EDF-BACC-621EADC6414FQ36047040-26F67862-36FB-4250-A173-526FADADA84CQ36924831-55AB1CE7-F150-47BB-8A12-9D4EDC079507Q36948336-2ABF36EF-EDCA-456F-BDB4-95CA6FBBCFC2Q37233474-E6245FC5-5F64-478D-B9F1-7DEE28698114Q37250824-9B447B43-6BE1-4C78-8E3C-45B393DB9AB4Q37475917-127B8594-94BE-4197-B274-0877CFE5CFE8Q37714562-B16A161C-7A4D-4C05-B101-D43F4748DF90Q37878464-306BC4D0-AA2D-4E72-9794-9BCA359BC8D1Q38275010-3382E504-1CC9-4242-A4B9-5F67BEA19717Q38596777-ACF7F383-B44F-4D4E-92B6-B39062F9FDFEQ39852672-8F35D217-F0E7-4750-AF39-F58C275A917EQ39968883-D8A26E5F-BC26-4AD8-AD6F-DCCA21482A27Q42157554-F5A6E47C-ED68-443A-A9DF-0B9F60891F56Q42835351-EBB35CFD-24F7-46F3-B633-F18C134EE743Q54387343-A12061F5-6652-4B40-9C16-BE9A77555794
P2860
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cumulative effect of five gene ...... in multiple study populations.
@ast
Cumulative effect of five gene ...... in multiple study populations.
@en
Cumulative effect of five gene ...... in multiple study populations.
@nl
type
label
Cumulative effect of five gene ...... in multiple study populations.
@ast
Cumulative effect of five gene ...... in multiple study populations.
@en
Cumulative effect of five gene ...... in multiple study populations.
@nl
prefLabel
Cumulative effect of five gene ...... in multiple study populations.
@ast
Cumulative effect of five gene ...... in multiple study populations.
@en
Cumulative effect of five gene ...... in multiple study populations.
@nl
P2093
P2860
P50
P356
P1433
P1476
Cumulative effect of five gene ...... in multiple study populations.
@en
P2093
Bao-Li Chang
Bruce J Trock
David Duggan
Fredrik Wiklund
Jielin Sun
John D Carpten
Kathleen E Wiley
Patrick C Walsh
Pär Stattin
S Lilly Zheng
P2860
P304
P356
10.1002/PROS.20793
P577
2008-09-01T00:00:00Z